2020年3月26日 · Gestational Diabetes Mellitus. The purposes of this document are to provide a brief overview of the understanding of GDM, review management guidelines that have been validated by appropriately conducted clinical research, and identify gaps in current knowledge toward which future research can be directed.

ABSTRACT: Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. . However, debate continues to surround the diagnosis and treatment of GDM despite several recent large-scale studies addressing these iss

One woman describes her experience with gestational diabetes, from getting the diagnosis and following a treatment plan to giving birth to a healthy baby.

This ACOG patient education pamphlet offers easy-to-digest information for patients about gestational diabetes with a focus on how this condition develops, the risk factors, testing, and management during pregnancy.

2021年5月20日 · Number 828 (Reaffirmed 2024) Committee on Obstetric Practice. Society for Maternal-Fetal Medicine. This Committee Opinion was developed by the Committee on Obstetric Practice in collaboration with committee members Rita Wesley Driggers, MD and Allison S. Bryant, MD, MPH and the Society for Maternal-Fetal Medicine in collaboration with Alessandro …

2021年6月24日 · Number 831 (Replaces Committee Opinion Number 818, February 2024) Committee on Obstetric Practice ...

ABSTRACT: Pregestational diabetes mellitus represents one of the most challenging medical complications of pregnancy because of the need for frequent monitoring and adjustment of medications as well as the potential for maternal and fetal complications.

ABSTRACT: The goal of antepartum fetal surveillance is to reduce the risk of stillbirth.Antepartum fetal surveillance techniques based on assessment of fetal heart rate (FHR) patterns have been in clinical use for almost four decades and are used along with real-time ultrasonography and umbilical artery Doppler velocimetry to evaluate fetal well-being.

Recommendations. The American College of Obstetricians and Gynecologists makes the following recommendations: A single course of corticosteroids is recommended for pregnant women between 24 0/7 weeks and 33 6/7 weeks of gestation who are at risk of preterm delivery within 7 days, including for those with ruptured membranes and multiple gestations.